News
-
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: Vita 34 AG (von Montega AG): Kaufen (zuvor: Halten)
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: Vita 34 AG (von Montega AG): Halten
-
-
COMMUNIQUÉ DE PRESSE
Vita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Candidate
-
COMMUNIQUÉ DE PRESSE
Original-Research: Vita 34 AG (von Montega AG): Halten
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Vita 34 AG publishes outlook for the 2023 financial year